Omnicell (NASDAQ:OMCL) Shares Gap Up - Should You Buy?

Omnicell, Inc. (NASDAQ:OMCL - Get Free Report)'s share price gapped up prior to trading on Thursday . The stock had previously closed at $27.34, but opened at $30.28. Omnicell shares last traded at $30.13, with a volume of 192,663 shares traded.

Wall Street Analyst Weigh In

OMCL has been the topic of a number of research reports. Benchmark cut their price objective on Omnicell from $62.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. JPMorgan Chase & Co. cut their price objective on Omnicell from $44.00 to $36.00 and set a "neutral" rating on the stock in a report on Thursday, March 20th. Wells Fargo & Company raised their price objective on Omnicell from $35.00 to $37.00 and gave the stock an "overweight" rating in a report on Friday. Bank of America raised their price objective on Omnicell from $30.00 to $34.00 and gave the stock a "neutral" rating in a report on Friday. Finally, Wall Street Zen upgraded Omnicell from a "hold" rating to a "buy" rating in a report on Tuesday. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $44.83.

Omnicell Price Performance

The company has a debt-to-equity ratio of 0.13, a current ratio of 1.37 and a quick ratio of 1.22. The company's 50-day simple moving average is $30.94 and its 200-day simple moving average is $38.72. The company has a market cap of $1.32 billion, a price-to-earnings ratio of 104.56, a P/E/G ratio of 7.53 and a beta of 0.78.

Omnicell (NASDAQ:OMCL - Get Free Report) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.10. Omnicell had a net margin of 1.13% and a return on equity of 3.82%. The company had revenue of $269.67 million during the quarter, compared to the consensus estimate of $260.18 million. During the same quarter last year, the company earned $0.03 earnings per share. Omnicell's revenue for the quarter was up 9.5% on a year-over-year basis. On average, equities research analysts anticipate that Omnicell, Inc. will post 1.09 EPS for the current year.

Institutional Trading of Omnicell

Large investors have recently bought and sold shares of the company. Shaker Investments LLC OH acquired a new stake in Omnicell in the fourth quarter valued at approximately $550,000. Empowered Funds LLC acquired a new stake in shares of Omnicell during the fourth quarter worth approximately $388,000. Exchange Traded Concepts LLC grew its position in shares of Omnicell by 6.7% during the fourth quarter. Exchange Traded Concepts LLC now owns 319,682 shares of the company's stock worth $14,232,000 after buying an additional 20,031 shares in the last quarter. Jane Street Group LLC grew its position in shares of Omnicell by 7.4% during the fourth quarter. Jane Street Group LLC now owns 54,282 shares of the company's stock worth $2,417,000 after buying an additional 3,725 shares in the last quarter. Finally, SG Americas Securities LLC grew its position in shares of Omnicell by 56.5% during the fourth quarter. SG Americas Securities LLC now owns 39,359 shares of the company's stock worth $1,752,000 after buying an additional 14,202 shares in the last quarter. Institutional investors and hedge funds own 97.70% of the company's stock.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.